Elanco Animal HealthELAN
紐約證券 · USD
23.95
+0.39
(+1.66%)
盤中 08/21 09:39 (UTC+8)
08/21 09:39 (UTC+8)
Elanco Animal HealthELAN
23.95
+0.39
(+1.66%)
財務數據
損益表
- 12.05
- 11.84
- 10.30
- 10.20
- 11.93
- 12.41
- 11.37
- 11.44
- 13.71
- 13.68
- 16.43
- -1.74
- -13.01
- -0.97
- 16.96
- 4.02
- -8.38
- 0.62
- 19.84
- -0.22
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 1,368,000 | 1,371,000 | 1,144,000 | 1,137,000 | 1,241,000 | 1,193,000 | 1,020,000 | 1,030,000 | 1,184,000 | 1,205,000 |
營業成本 | 570,000 | 586,000 | 555,000 | 530,000 | 528,000 | 509,000 | 501,000 | 492,000 | 495,000 | 515,000 |
營業毛利 | 798,000 | 785,000 | 589,000 | 607,000 | 713,000 | 684,000 | 519,000 | 538,000 | 689,000 | 690,000 |
營業費用 | 689,000 | 632,000 | 772,000 | 605,000 | 629,000 | - | - | - | - | - |
研發費用 | 92,000 | 97,000 | 93,000 | 89,000 | 92,000 | 94,000 | 81,000 | 87,000 | 89,000 | 87,000 |
推銷及管理費用 | 449,000 | 381,000 | 338,000 | 351,000 | 400,000 | 341,000 | 300,000 | 323,000 | 354,000 | 337,000 |
非經常性項目費用 | 9,000 | 16,000 | 202,000 | 25,000 | 1,000 | 9,000 | 7,000 | 17,000 | 80,000 | 46,000 |
其他營業費用 | 139,000 | 138,000 | 139,000 | 140,000 | 136,000 | 128,000 | 130,000 | 133,000 | 131,000 | 133,000 |
營業利益 | 109,000 | 153,000 | -183,000 | 2,000 | 84,000 | 112,000 | 1,000 | -22,000 | 35,000 | 87,000 |
其他收入及費用 | 6,000 | -9,000 | 4,000 | - | -11,000 | -12,000 | -6,000 | 639,000 | -2,000 | -9,000 |
利息費用 | 59,000 | 57,000 | 80,000 | 52,000 | 48,000 | 40,000 | 46,000 | 58,000 | 65,000 | 66,000 |
稅前純益 | 56,000 | 87,000 | -259,000 | -50,000 | 25,000 | 60,000 | -51,000 | 559,000 | -32,000 | 12,000 |
所得稅 | 2,000 | 30,000 | 17,000 | -16,000 | 14,000 | -7,000 | -43,000 | 195,000 | 18,000 | -20,000 |
稅後純益 | 54,000 | 57,000 | -276,000 | -34,000 | 11,000 | 67,000 | -8,000 | 364,000 | -50,000 | 32,000 |
基本每股稅後盈餘(元) | 0.11 | 0.11 | -0.56 | -0.07 | 0.02 | 0.14 | -0.02 | 0.74 | -0.10 | 0.06 |
稀釋每股稅後盈餘(元) | 0.11 | 0.11 | -0.56 | -0.07 | 0.03 | 0.13 | -0.02 | 0.74 | -0.10 | 0.06 |
基本平均股數(千股) | 499500.00 | 497700.00 | 496900.00 | 496800.00 | 496600.00 | 495100.00 | 494400.00 | 494300.00 | 494200.00 | 493200.00 |
稀釋平均股數(千股) | 505900.00 | 506000.00 | 496900.00 | 496800.00 | 500100.00 | 499100.00 | 494400.00 | 497700.00 | 494200.00 | 496000.00 |
還原基本每股稅後盈餘(元) | 0.11 | 0.11 | -0.56 | -0.07 | 0.02 | 0.14 | -0.02 | 0.74 | -0.10 | 0.06 |
還原稀釋每股稅後盈餘(元) | 0.11 | 0.11 | -0.56 | -0.07 | 0.03 | 0.13 | -0.02 | 0.74 | -0.10 | 0.06 |
還原基本平均股數(千股) | 499,500 | 497,700 | 496,900 | 496,800 | 496,600 | 495,100 | 494,400 | 494,300 | 494,200 | 493,200 |
還原稀釋平均股數(千股) | 505,900 | 506,000 | 496,900 | 496,800 | 500,100 | 499,100 | 494,400 | 497,700 | 494,200 | 496,000 |
EBITDA(千元) | 286,000 | 316,000 | -5,000 | 178,000 | 242,000 | 261,000 | 159,000 | 787,000 | 195,000 | 244,000 |